Bristol-Myers Squibb Company (BCBA:BMY)

Argentina flag Argentina · Delayed Price · Currency is ARS
29,380
-580 (-1.94%)
Last updated: Feb 10, 2026, 1:06 PM BRT
Market Cap176.25T +39.1%
Revenue (ttm)69.95T -0.2%
Net Income10.24T
EPS5,021.84
Shares Outn/a
PE Ratio17.22
Forward PE9.81
Dividend679.97 (2.31%)
Ex-Dividend DateJan 2, 2026
Volume103
Average Volume2,063
Open29,700
Previous Close29,960
Day's Range29,380 - 29,940
52-Week Range16,950 - 30,900
Betan/a
RSI66.73
Earnings DateFeb 5, 2026

About BCBA:BMY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products for oncology, hematology, immunology, cardiovascular, neuroscience, and other areas. The company’s products include Eliquis for reduction in risk of stroke/systemic embolism in non-valvular atrial fibrillation and for the treatment of DVT/PE; Opdivo for various anti-cancer indications; Pomalyst/Imnovid for multiple myeloma; Orencia for active rheumatoid arthritis and psoriatic arthrit... [Read more]

Industry Pharmaceutical Preparations
Founded 1887
Employees 34,100
Stock Exchange Buenos Aires Stock Exchange
Ticker Symbol BMY
Full Company Profile

Financial Performance

Financial numbers in USD Financial Statements